Moderate Aortic Stenosis and Coronary Artery Bypass Grafting: Clinical Update for the Perioperative Echocardiographer

Yasdet Maldonado1, Saket Singh1, John G Augoustides2

  • 1Department of Anesthesiology, Allegheny Health Network, Temple University School of Medicine, Pittsburgh, PA;

Insights

Managing incidental aortic stenosis during coronary artery bypass surgery requires careful assessment. A balanced approach considering patient factors and evolving valve technologies is crucial for moderate cases.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Incidental aortic stenosis presents a perioperative challenge during coronary artery bypass surgery (CABG).
  • Accurate assessment of aortic stenosis severity is critical for guiding management decisions.
  • Current guidelines recommend a balanced approach for moderate aortic stenosis in the context of CABG.

Purpose of the Study:

  • To discuss the challenges and considerations for managing incidental aortic stenosis in patients undergoing CABG.
  • To highlight the importance of a multidisciplinary team approach in decision-making.
  • To acknowledge the evolving landscape of aortic valve technologies for potential future interventions.

Main Methods:

  • Review of current guidelines and clinical considerations for aortic stenosis management.
  • Discussion of factors influencing risk-benefit analysis for surgical and interventional options.
  • Consideration of advancements in aortic valve replacement and repair technologies.

Main Results:

  • Accurate assessment of aortic stenosis degree is paramount.
  • Severe aortic stenosis typically warrants valve replacement.
  • Management of moderate aortic stenosis requires individualized, team-based decision-making balancing risks and benefits.

Conclusions:

  • Management of incidental aortic stenosis during CABG is complex and requires careful consideration of multiple factors.
  • A multidisciplinary team approach is essential for optimizing patient outcomes.
  • Emerging aortic valve technologies offer promising future alternatives for managing moderate aortic stenosis in this patient population.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
432
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
469
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
582
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
381